Midazolam hydrochloride
- Product NDC
- 64679-765
- 11-digit product format
- 646790765
- Labeler code
- 64679
- Product ID
- 64679-765_209d926b-f1af-49e2-be94-53c7035b0b93
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Midazolam hydrochloride
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Wockhardt USA LLC.
- Application
- ANDA078511
- Marketing category
- ANDA
- Marketing start
- 2008-11-10
- Marketing end
- 0000-00-00
- Substance
- MIDAZOLAM HYDROCHLORIDE
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Benzodiazepine [EPC],Benzodiazepines [CS]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 64679-765-01 | 2024-11-21 | C162847 | 48780-1 | 9d75b9d0-482e-f424-e053-dadaa90a57ce | c9c15206-e694-42f2-af87-9c115de2ce37 |
| 64679-765-02 | 2024-11-21 | C162847 | 48780-1 | 9d75b9d0-482e-f424-e053-dadaa90a57ce | c9c15206-e694-42f2-af87-9c115de2ce37 |
| 64679-765-03 | 2024-11-21 | C162847 | 48780-1 | 9d75b9d0-482e-f424-e053-dadaa90a57ce | c9c15206-e694-42f2-af87-9c115de2ce37 |
| 64679-765-04 | 2024-11-21 | C162847 | 48780-1 | 9d75b9d0-482e-f424-e053-dadaa90a57ce | c9c15206-e694-42f2-af87-9c115de2ce37 |
| 64679-765-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-482e-f424-e053-dadaa90a57ce | c9c15206-e694-42f2-af87-9c115de2ce37 |
| 64679-765-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-482e-f424-e053-dadaa90a57ce | c9c15206-e694-42f2-af87-9c115de2ce37 |
| 64679-765-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-482e-f424-e053-dadaa90a57ce | c9c15206-e694-42f2-af87-9c115de2ce37 |
| 64679-765-04 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-482e-f424-e053-dadaa90a57ce | c9c15206-e694-42f2-af87-9c115de2ce37 |